EURETINA 2021 Virtual Congress Report Article; Using artificial intelligence to predict injection frequency by Dr. Maximillian Pfau
EURETINA 2021 Virtual Congress Report Article;Corticosteroid implant reduces recurrence rates in non-infectious uveitis by Dr. Carlos Pavesio
EURETINA 2021 Virtual Congress Report Article; Identifying biomarkers for early geographic atrophy by Dr. Steffen Schmitz Valckenberg
Educational Webinars: Central Serous Chorioretinopathy (CSC): Shedding an Evidence-Based Light on a Mysterious Disease (7 October 2021)
View the 60-minute educational webinar, chaired by Camiel Boon (Leiden University Medical Centre, Netherlands), hosting an international panel of 6 retina specialists on the diagnosis and management of CSC.
Learn more about the results of the 2020 EURETINA AMD and DME Clinical Trends Survey, as discussed by Prof Anat Loewenstein, during the EURETINA Virtual Congress 2021.
Positive Phase 3 results on C3 Inhibition in geographic atrophy due to age-related macular degeneration
Learn more about the history of EURETINA from the founders of the Society as we celebrate the past 21 years.
This year, we will be celebrating our 21st Congress. Over the last 21 years, due in large part to the valued community, Euretina has grown exponentially and continues to evolve.
With just a few weeks remaining until the opening of EURETINA 2021 virtual, organizers are promising a congress that will offer a rich and varied mix of science and education covering all the latest topics…
As part of its ambitious 2025 Roadmap, EURETINA has launched a dedicated mentorship programme, sponsored by Roche and overseen by Executive Board members Anat Loewenstein and Ramin Tadayoni.